Blonder Tongue Laboratories, Inc. (BDR) saw its loss narrow to $0.34 million, or $0.04 a share for the quarter ended Dec. 31, 2016. In the previous year period, the company reported a loss of $2.14 million, or $0.32 a share.

Revenue during the quarter grew 4.51 percent to $5.45 million from $5.21 million in the previous year period. Gross margin for the quarter expanded 2356 basis points over the previous year period to 32.50 percent. Operating margin for the quarter stood at negative 5.36 percent as compared to a negative 38.63 percent for the previous year period.

Operating loss for the quarter was $0.29 million, compared with an operating loss of $2.01 million in the previous year period.

Commenting on the year end results, chief executive officer Robert J. Palle noted, "We were able to substantially narrow the losses for both the fourth quarter and the full year compared to 2015, but the overall results are disappointing and clearly indicate we still have a lot more to do in the areas of increasing sales and improving gross margin." Continuing, Mr. Palle said "In third quarter 2016, we reported that we would remain focused on achieving positive EBITDA and refinancing our revolver and term loan with a new lender. We achieved both of these goals and the details regarding each of these can be found in our 2016 Form 10-K. Also, as we previously indicated, we continue to project that sales will remain relatively flat for the first half of 2017."